https://adisinsight.springer.com/trials/700392564?error=cookies_not_supported&code=d895fe26-95b5-45e4-890d-cabb3cf90500
Clinical Study of Sonrotoclax Combined With Azacitidine Plus Individualized Targeted Drugs in the...
This is a phase II, open-label, multi-center study evaluating the efficacy and safety of sonrotoclax (SA) in combination with azacitidine (AZA) plus
https://africananalyst.blogspot.com/2025/12/sonrotoclax-data-at-ash-2025-confirm.html
African Analyst: Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell...
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combina...